Cab La News Today

The health department says ViiV Healthcare’s newly announced non-profit price — between R540 and R570 per shot — for a two-monthly anti-HIV jab is more than four times what it can afford to pay.

Towards the end of the year, donated batches of the anti-HIV jab CAB-LA will arrive in South Africa. The two-monthly jab will be used in implementation trials and virtually wipes out one’s chances of contracting HIV through sex.

Amid the festivities during the opening ceremony of the 11th SA AIDS Conference in Durban on Tuesday, there were several sobering moments.

Bhekisisa spoke to three women who’ve become HIV prevention advocates in their communities. They also tell us how the CAB-LA injection has changed their lives

South Africa’s medicine regulator, Sahpra, has registered CAB-LA, a new anti-HIV jab. But for how much will drugmaker ViiV Healthcare sell it to the government?

South Africa’s medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days. If the shot is approved, the health department could start rolling it out on a large scale within nine months — but that depends on the injection’s price.

South Africa had 200,000 new HIV infections in 2021, according to UNAids. A new injection called CAB-LA could be a game-changer

While the world has focused on the Covid-19 pandemic for nearly three years, less and less attention is being paid to HIV.

Phelokazi Ntliziywana, 22, of Crossroads in Cape Town confesses that she loves to be out and about and going partying.

Ive.org/2/items/CNNW_20171122_020000_Anderson_Cooper_360/CNNW_20171122_020000_Anderson_Cooper_360.thumbs/CNNW_20171122_020000_Anderson_Cooper_360_001018.jpg"/>